Document is current
Any future updates will be listed below
-
Authors
Kato, Ryo
Yamasaki, Makoto
Urakawa, Shinya
Nishida, Kentaro
Makino, Tomoki
Morimoto-Okazawa, Akiko
Kawashima, Atsunari
Iwahori, Kota
Suzuki, Susumu
Ueda, Ryuzo
Mori, Masaki
Satoh, Taroh
Doki, Yuichiro
Wada, Hisashi https://orcid.org/0000-0002-5444-6193
-
Funding
Funding for this research was provided by:
the Project for Development of Innovative Research on Cancer Therapeutics
Japan Agency for Medical Research and Development (15ck0106159h)
- License Information
-
More Information
Article History
Received: 5 April 2018
Accepted: 1 August 2018
First Online: 20 August 2018
Compliance with ethical standards
:
: None of the authors have any potential conflicts of interest to disclose.
: The clinical trial was registered at clinicaltrials.jp, number ONO-4538-07/JapicCTI-No.142422. The present study was approved by the Institutional Ethics Committee of Osaka University Hospital (#13266).
: All patients in the present study provided written informed consent before sampling and the collection of clinicopathological data according to the Declaration of Helsinki.
